Prosonix describe their latest advanced ultrasonic particle engineering developments in a feature article entitled "Power Ultrasound and the Production of Mesoscopic Particles and Aqueous Dispersions". For full details visit www.pharmtech.com, or read the special supplement pages s28-s35 accompanying the September 2008, Volume 32, 9 edition of Pharmaceutical Technology.
03 Feb 2012 - Geoff Down appointed as Chief Medical Officer Prosonix Appoints Respiratory Drug Development Expert Dr Geoff Down as Chief Medical Officer
Prosonix (Oxford, UK), an emerging pharmaceutical company developing a portfolio of enhanced respiratory...